Who owns Ernexa Therapeutics Inc?
- Ticker: ERNA
- CUSIP Number: 114082308
Tip: Access positions for across all investors
Analyze quarterly positions in Ernexa Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Ernexa Therapeutics stock
Who bought or sold Ernexa Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| CI Private Wealth | 438k | $480k | 2400% | Sep 2025 |
|
| Susquehanna International | 31k | $34k | 100% | Sep 2025 |
|
| Geode Capital Management | 21k | $22k | 2% | Sep 2025 |
|
| Vanguard Group | 11k | $12k | 100% | Sep 2025 |
|
| Sippican Capital Adivsors | 10k | $11k | 0% | Sep 2025 |
|
| Tower Research Capital | 5.2k | $5.7k | 100% | Sep 2025 |
|
| BlackRock | 820.00 | $897.982000 | 0% | Sep 2025 |
|
| Morgan Stanley | 554.00 | $1.0k | 100% | Jun 2025 |
|
| Assetmark | 133.00 | $145.994100 | 0% | Sep 2025 |
|
| EverSource Wealth Advisors | 116.00 | $126.996800 | 0% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 10.00 | $11.000000 | 0% | Sep 2025 |
|
| A. Montag and Associates | 8.00 | $9.000000 | 0% | Sep 2025 |
|
| Activest Wealth Management | 3.00 | $3.000000 | 0% | Sep 2025 |
|
Who sold out of Ernexa Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| UBS Group | Jun 2025 | 548.00 | $1.0k |